Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Notes Receivable: ₽0.0 Mil (As of Dec. 2023)


MIC:GEMA Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA
17 GF Score
Price ₽110.00
View Full Analysis

What is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Notes Receivable?

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA +0.55% 17 Notes Receivable is ₽0.0 Mil as of Dec. 2023. GuruFocus rates MIC:GEMA with a GF Score™ of 17/100.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Notes Receivable for the quarter that ended in Dec. 2023 was ₽0.0 Mil.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Notes Receivable Related Terms

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Notes Receivable Historical Data

* Premium members only.

The historical data trend for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Notes Receivable Chart

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MIC:GEMA
17GF Score
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₽0.0 Mil mean?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a Notes Receivable of ₽0.0 Mil as of Dec. 2023. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Notes Receivable too high?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current Notes Receivable is ₽0.0 Mil. Overall, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Notes Receivable compare to FICO and SPSC?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Notes Receivable of ₽0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current Notes Receivable is ₽0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC stock overvalued right now?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a current Notes Receivable of ₽0.0 Mil. The current Notes Receivable is ₽0.0 Mil. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA), the current Notes Receivable is ₽0.0 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Business Description

Address Ulitsa Gubkina, d. 3, Building 1, Floor 1, Moscow, RUS, 119333
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation, and Umbilical Cord tissue, among others.
17GF Score

Get the complete analysis for MIC:GEMA

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₽110.00
Price